Fecal Incontinence Market Report 2026

Fecal Incontinence Market Report 2026
Global Outlook – By Product Type (Absorbent Products, Anal Inserts, Electrical Stimulation Devices, Other Product Types), By Age Group (Pediatric, Adult, Geriatric), By Application (Hospitals, Clinics, Home Care Settings, Other Applications), By Distribution Channel (Online Stores, Pharmacies, Specialty Stores, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2026-2035
Fecal Incontinence Market Overview
• Fecal Incontinence market size has reached to $2.32 billion in 2025 • Expected to grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Rising Prevalence Of Gastrointestinal Disorders Driving The Growth Of The Market Due To Increasing Cases And Lifestyle Changes • Market Trend: Revolutionizing Fecal Incontinence Treatment with At-Home Non-Invasive Solutions For Women With Chronic Conditions • North America was the largest region in 2025.What Is Covered Under Fecal Incontinence Market?
Fecal incontinence is the involuntary loss of bowel control, leading to the unintentional passing of stool or gas. It can range from occasional leakage of stool while passing gas to a complete loss of bowel control. Causes may include muscle or nerve damage, diarrhea, constipation, or underlying medical conditions such as inflammatory bowel disease or neurological disorders. The main product types in fecal incontinence include absorbent products, anal inserts, electrical stimulation devices, and other product types. Absorbent products help manage fecal incontinence by preventing leaks and providing comfort. These products are used across different age groups, including pediatric, adult, and geriatric populations, and are applied in hospitals, clinics, home care settings, and other applications. They are distributed through various channels, including online stores, pharmacies, specialty stores, and other distribution channels.
What Is The Fecal Incontinence Market Size and Share 2026?
The fecal incontinence market size has grown strongly in recent years. It will grow from $2.32 billion in 2025 to $2.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising geriatric population levels, increasing prevalence of gastrointestinal disorders, wider availability of disposable continence products, growing awareness of bowel health conditions, improved diagnosis of pelvic floor dysfunction.What Is The Fecal Incontinence Market Growth Forecast?
The fecal incontinence market size is expected to see strong growth in the next few years. It will grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing adoption of non-invasive treatment approaches, rising demand for personalized continence care, growing home healthcare penetration, expansion of digital pelvic floor therapy tools, increasing healthcare focus on quality of life improvement. Major trends in the forecast period include increasing adoption of advanced absorbent products, rising use of electrical stimulation therapies, growing preference for home-based management solutions, expansion of minimally invasive treatment options, enhanced focus on patient comfort and discretion.Global Fecal Incontinence Market Segmentation
1) By Product Type: Absorbent Products, Anal Inserts, Electrical Stimulation Devices, Other Product Types 2) By Age Group: Pediatric, Adult, Geriatric 3) By Application: Hospitals, Clinics, Home Care Settings, Other Applications 4) By Distribution Channel: Online Stores, Pharmacies, Specialty Stores, Other Distribution Channels Subsegments: 1) By Absorbent Products: Adult Diapers, Protective Underwear, Pads And Liners 2) By Anal Inserts: Disposable Anal Inserts, Reusable Anal Inserts 3) By Electrical Stimulation Devices: Implantable Devices, Non-Implantable Devices 4) By Other Product Types: Biofeedback Systems, Injectable Bulking Agents, Surgical DevicesWhat Is The Driver Of The Fecal Incontinence Market?
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the fecal incontinence market going forward. Gastrointestinal (GI) disorders are conditions that affect the digestive system, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder. The prevalence of gastrointestinal disorders is increasing due to poor dietary habits and lifestyle changes, such as high consumption of processed foods and low fiber intake. Gastrointestinal disorders such as inflammatory bowel disease (IBD), chronic diarrhea, and irritable bowel syndrome (IBS) can cause fecal incontinence by disrupting bowel function in multiple ways. For instance, in June 2023, Crohn's and Colitis Canada, a Canada-based charity focused on helping and improving the lives of people living with Crohn's or colitis, the number of people living with inflammatory bowel disease (IBD) is expected to rise from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). Additionally, 11,000 new cases were projected for 2023 (equivalent to one diagnosis every 48 minutes), increasing to 14,000 new cases in 2035 (one every 38 minutes). Therefore, the rising prevalence of gastrointestinal disorders is driving the growth of the fecal incontinence industry.Key Players In The Global Fecal Incontinence Market
Major companies operating in the fecal incontinence market are 3M Company, Medtronic plc, Medline Industries LP, Essity AB, B. Braun Melsungen AG, Domtar Corporation, Coloplast Corp., HARTMANN Direct, ConvaTec Group plc, Ontex Group NV, Hollister Incorporated, Abena Group, Laborie Medical Technologies, Home Care Delivered, 180 Medical, Attends Healthcare Products Inc., Principle Business Enterprises Inc., Carewell, NorthShore Care Supply, InControl Medical, Tranquility Products, Aeroflow Urology, Reliance Medical Inc., TZMO SA, Allegro MedicalGlobal Fecal Incontinence Market Trends and Insights
Major companies operating in the fecal incontinence market are focusing on developing innovative solutions such as pelvic health systems to improve patient comfort, enhance treatment outcomes, and expand market reach. A pelvic health system refers to a range of medical technologies, services, and treatments aimed at diagnosing, managing, and improving the health of the pelvic organs and structures. These systems are typically designed to address conditions affecting the pelvic floor, including incontinence, pelvic pain, and reproductive health issues. For instance, in June 2023, Axena Health Inc., a US-based medical device company, introduced the Leva pelvic health system with U.S. Food and Drug Administration clearance. This innovative system offers a convenient, non-invasive, and drug-free approach to strengthening pelvic floor muscles, using motion sensors and real-time feedback to guide users through effective five-minute daily exercises. By improving accessibility and efficacy through telehealth integration, the system specifically targets fecal incontinence, offering a practical solution for patients.What Are Latest Mergers And Acquisitions In The Fecal Incontinence Market?
In January 2024, Boston Scientific Corporation, a US-based medical technology company, acquired Axonics Inc. for $3.7 billion. With this acquisition, Boston Scientific Corporation aims to significantly enhance its urology portfolio by integrating Axonics' innovative technologies for treating urinary and bowel dysfunction. Axonics Inc. is a US-based medical device company specializing in neuromodulation solutions for treating conditions such as overactive bladder (OAB), fecal incontinence, and urinary retention.Regional Outlook
North America was the largest region in the fecal incontinence market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Fecal Incontinence Market?
The fecal incontinence market consists of revenues earned by entities by providing services such as medical treatments, pelvic floor rehabilitation, surgical interventions, consultation, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The fecal incontinence market also includes sales of bowel management systems, anti-diarrheal drugs, laxatives, stool softeners, artificial sphincters, and nerve stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Fecal Incontinence Market Report 2026?
The fecal incontinence market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fecal incontinence industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Fecal Incontinence Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.47 billion |
| Revenue Forecast In 2035 | $3.18 billion |
| Growth Rate | CAGR of 6.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Age Group, Application, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | 3M Company, Medtronic plc, Medline Industries LP, Essity AB, B. Braun Melsungen AG, Domtar Corporation, Coloplast Corp., HARTMANN Direct, ConvaTec Group plc, Ontex Group NV, Hollister Incorporated, Abena Group, Laborie Medical Technologies, Home Care Delivered, 180 Medical, Attends Healthcare Products Inc., Principle Business Enterprises Inc., Carewell, NorthShore Care Supply, InControl Medical, Tranquility Products, Aeroflow Urology, Reliance Medical Inc., TZMO SA, Allegro Medical |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Fecal Incontinence market was valued at $2.32 billion in 2025, increased to $2.47 billion in 2026, and is projected to reach $3.18 billion by 2030.
request a sample hereThe global Fecal Incontinence market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $3.18 billion by 2035.
request a sample hereSome Key Players in the Fecal Incontinence market Include, 3M Company, Medtronic plc, Medline Industries LP, Essity AB, B. Braun Melsungen AG, Domtar Corporation, Coloplast Corp., HARTMANN Direct, ConvaTec Group plc, Ontex Group NV, Hollister Incorporated, Abena Group, Laborie Medical Technologies, Home Care Delivered, 180 Medical, Attends Healthcare Products Inc., Principle Business Enterprises Inc., Carewell, NorthShore Care Supply, InControl Medical, Tranquility Products, Aeroflow Urology, Reliance Medical Inc., TZMO SA, Allegro Medical .
request a sample hereMajor trend in this market includes: Revolutionizing Fecal Incontinence Treatment with At-Home Non-Invasive Solutions For Women With Chronic Conditions. For further insights on this market.
request a sample hereNorth America was the largest region in the fecal incontinence market in 2025. The regions covered in the fecal incontinence market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here